Status:
COMPLETED
A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis
Lead Sponsor:
Duo Zhang
Conditions:
Complication
Eligibility:
FEMALE
50-50 years
Brief Summary
Polyacrylamide hydrogel (PAAG) has been used as an injectable filler for soft tissue augmentation in different parts of the body , such as face, breast , or even penis for more than a decade . However...
Eligibility Criteria
Inclusion
- PAAG injected into bilateral temporal epicranial aponeurosis
Exclusion
- PAAG injected into other parts of the body
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01519362
Start Date
October 1 2011
Last Update
January 26 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.